0001179110-17-011728.txt : 20170822
0001179110-17-011728.hdr.sgml : 20170822
20170822163700
ACCESSION NUMBER: 0001179110-17-011728
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170820
FILED AS OF DATE: 20170822
DATE AS OF CHANGE: 20170822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: dEsparbes Eric
CENTRAL INDEX KEY: 0001622268
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 171045513
MAIL ADDRESS:
STREET 1: THERAVANCE, INC.
STREET 2: 951 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
edgar.xml
FORM 4 -
X0306
4
2017-08-20
0
0001080014
Innoviva, Inc.
INVA
0001622268
dEsparbes Eric
2000 SIERRA POINT PARKWAY
SUITE 500
BRISBANE
CA
94005
0
1
0
0
SVP and CFO
Common Stock
2017-08-20
4
F
0
5770
12.28
D
344993
D
Common Stock
2017-08-21
4
S
0
1825
12.20
D
343168
D
The shares were withheld by the Company to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.
This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.
/s/ Eric d'Esparbes
2017-08-22